Previous 10 | Next 10 |
VolitionRx Limited Announces Third Quarter 2023 Financial Results and Business Update PR Newswire Conference call to discuss financial and operational results scheduled for Wednesday, November 15 , at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev. , ...
2023-11-14 10:52:25 ET Major earnings expected before the bell on Wednesday include: JD.com ( JD ) Tencent Holdings ( OTCPK:TCEHY ) Target ( TGT ) XPeng ( XPEV ) ZIM Integrated Shipping Services ( ZIM ) For further details see: Notable ear...
VolitionRx Limited Schedules Third Quarter 2023 Earnings Conference Call and Business Update PR Newswire Conference call to take place on Wednesday November 15 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev. , Nov. 8, 2023 /PRNewswire/ -- VolitionRx...
Volition Presents Breakthrough Liquid Biopsy Blood Test Method for Early-stage Cancer PR Newswire HENDERSON, Nev. , Oct. 23, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has unveiled what it bel...
Measuring Nucleosomes Using Nu.Q® NETs is a Promising Biomarker for Septic Shock PR Newswire HENDERSON, Nev. , Oct. 19, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the publicatio...
US Ambassador Adler visits Belgian Volition PR Newswire HENDERSON, Nev. , Oct. 18, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, welcomed Ambassador Michael M. Adler , U.S. Ambassador to...
Volition Presents Three Cancer Detection Abstracts at ESMO 2023 PR Newswire HENDERSON, Nev. , Oct. 16, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is presenting three scientific abstracts a...
Volition Publishes Key Opinion Leader Roundtable Report on NETs in Sepsis PR Newswire HENDERSON, Nev. , Oct. 13, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has published a report summarisi...
Volition to Reveal New Cancer Detection Method Insights at Upcoming Webinar PR Newswire HENDERSON, Nev. , Oct. 2, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar ho...
2023-09-22 12:52:13 ET For further details see: CETX, MYO and MORF among mid-day movers
News, Short Squeeze, Breakout and More Instantly...
VolitionRx Limited (NYSE American: VNRX) , a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, announced the engagement of PharmaVentures Ltd (“PharmaVentures”) to act as an advisor. PharmaVentures w...
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing PR Newswire HENDERSON, Nev. , July 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed PharmaV...
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...